Furthermore, inhibition of insulin secretion during STZ-induced chronic pancreatic inflammation may be associated with attenuated expression of SPARC and thus mediated dysregulation of β-cell function in the diabetic pancreas. This evidence concerns the gene SPARC and inflammation.